GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Magle Chemoswed Holding AB (OSTO:MAGLE) » Definitions » Price-to-Funds-From-Operations

Magle Chemoswed Holding AB (OSTO:MAGLE) Price-to-Funds-From-Operations : (As of May. 29, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Magle Chemoswed Holding AB Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Magle Chemoswed Holding AB (OSTO:MAGLE) Business Description

Traded in Other Exchanges
N/A
Address
Agneslundsvagen 27, Malmo, SWE, 21215
Magle Chemoswed Holding AB is a contract development and manufacturing organization that serves companies in the pharmaceutical and medical device industry on a contract basis. It provides comprehensive services from product development through product manufacturing. The company's products portfolio includes Warfarin sodium, Melperone hydrochloride, Isradipine, Amantadine sulfate, and Benserazide hydrochloride.